Skip to content
Analyzing Health Effects

Analyzing Health Effects

Understanding Medical Impact

Analyzing Health Effects

Analyzing Health Effects

  • Advertise Here
  • Contact Us
  • Privacy Policy
  • Sitemap
  • Home
  • Phase

Phase

Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease | Trials
  • Kidney Health

Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease | Trials

admin August 29, 2025 0

Explanation for the choice of comparators {6b}Participants in the control group will receive matched identical placebo. A placebo-controlled trial was...

Read MoreRead more about Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease | Trials
WELL Provider Solutions Rebrands as ‘WELLSTAR’, Completes Two Tuck-in Acquisitions and Raises Private Capital to Support Its Pre-Spinout Phase of Growth
  • Health technology

WELL Provider Solutions Rebrands as ‘WELLSTAR’, Completes Two Tuck-in Acquisitions and Raises Private Capital to Support Its Pre-Spinout Phase of Growth

admin February 8, 2025 0

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ WELL has rebranded its subsidiary WELL...

Read MoreRead more about WELL Provider Solutions Rebrands as ‘WELLSTAR’, Completes Two Tuck-in Acquisitions and Raises Private Capital to Support Its Pre-Spinout Phase of Growth

Recent Posts

  • N.W.T. leaders say Ottawa is underfunding Indigenous health-care program by millions
  • Istios Health Expands Into Nephrology With Three Practice Partnerships
  • Could dentists help Europe beat cervical cancer?
  • TGH Innovation Week spotlights Tampa as health tech hub
  • Kidney care: the economics of innovation

Archives

Categories

  • ! Без рубрики
  • Bone and Joint Health
  • Dental health
  • Digestive System Health
  • Health technology
  • Kidney Health

Visit Us

Advancing Dynamic Operations

You may have missed

N.W.T. leaders say Ottawa is underfunding Indigenous health-care program by millions
  • Dental health

N.W.T. leaders say Ottawa is underfunding Indigenous health-care program by millions

admin February 24, 2026 0
Istios Health Expands Into Nephrology With Three Practice Partnerships
  • Kidney Health

Istios Health Expands Into Nephrology With Three Practice Partnerships

admin February 23, 2026 0
Could dentists help Europe beat cervical cancer?
  • Dental health

Could dentists help Europe beat cervical cancer?

admin February 23, 2026 0
TGH Innovation Week spotlights Tampa as health tech hub
  • Health technology

TGH Innovation Week spotlights Tampa as health tech hub

admin February 22, 2026 0
Kidney care: the economics of innovation
  • Kidney Health

Kidney care: the economics of innovation

admin February 22, 2026 0
Copyright © All rights reserved. | CoverNews by AF themes.